Employment history 

2015 – 2016    Research scientist  at LAAS CNRS, UPR 8001, Toulouse, France

2007 – 2015    Researcher associate at Institut CurieUMR 168, CNRS, Paris, France

2006 – 2007    Laboratory of Photonics and Nanostructures (LPN), France - Postdoctoral Fellow             

2004 – 2006    IBM Research Laboratory, Rüschlikon, Switzerland - Postdoctoral Fellow     


2004   Ph.D.,  Nanosciences and Nanotechnology, University of Toulouse - France

2000   M.S., National Institute of Applied Sciences, Toulouse - France 

1998   B.S., Material Sciences, University of Toulouse - France 


Research Activities

Over the past 13 years,  L. Malaquin has covered the fields of nanosciences, 3D microfabrication, microfluidics, molecular biology, cell biology, diagnosis in oncology.

From 2004 to 2007, L . Malaquin has focused has work on the development of self assembly and transfer techniques at the micro and nanoscale for the integration of active micro and nano particles in functional optical of microfluidic devices. This work was performed at IBM Zurich where he could gather a good experience in the development and valorisation of industrial projects.

From 2007 to 2015, L. Malaquin has developed novel microfluidic concepts and 2D/3D microfabrication technologies for lab on chip devices. His main goal was to solve i) exisiting issues in the field of biomolecular analysis for the pre-concentration, selective capture and detection of biomarkers ii) to develop new microfluidic devices for the capture, analysis and culture of living cells (Circulating tumoral cells, neurons,… ). These interdisciplinary activities were done in strong collaboration with biologists and clinicians in the field of oncology. A special care was devoted to the applicative aspects of these activities and the possibility to favour industrial transfer.

Since 2015, L. Malaquin continues his research activities in interdisciplinary project at LAAS CNRS with a special focus on the development of the understanding and control of the role of microenvironment on cancer initiation and spreading.  These activities rely on a strong technological development focused on 3D printing and 3D bioprinting.

In 2016, L. Malaquin has co-funded the Inorevia Startup company in September 2016 and will lead the MultiFab 3D printing platform that will be created in 2017 at LAAS CNRS.